Notably, SMARCA4-UT is associated with greater invasiveness and a poorer prognosis, in contrast to SMARCA4-dNSCLC, which demonstrates a clearer differentiation and a treatment response more akin to typical NSCLC. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.